Molecular Mechanisms of Drug Resistance in Glioblastoma
Glioblastoma multiforme (GBM) is the most common and fatal primary brain tumor, is highly resistant to conventional radiation and chemotherapy, and is not amenable to effective surgical resection. The present review summarizes recent advances in our understanding of the molecular mechanisms of thera...
Main Authors: | Maya A. Dymova, Elena V. Kuligina, Vladimir A. Richter |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/12/6385 |
Similar Items
-
Tumor suppressor WWOX and p53 alterations and drug resistance in glioblastomas
by: Ming-Fu eChiang, et al.
Published: (2013-03-01) -
Genetic Characteristics of Glioblastoma: Clinical Implications of Heterogeneity
by: Qian Li, et al.
Published: (2015-01-01) -
Metástases intrarraquidianas de glioblastoma multiforme supratentorial da infância: relato de caso Spinal cord metastatic glioblastoma multiforme of childhood: case report
by: Patricia Imperatriz Porto Rondinelli, et al.
Published: (2002-09-01) -
Assessing current therapeutic approaches to decode potential resistance mechanisms in glioblastomas
by: Chun-I eSze, et al.
Published: (2013-03-01) -
Adjuvant uzatılmış temozolamid tedavisinin glioblastoma multiforme hastalarının sağkalımına etkisi
by: Berna YILDIRIM, et al.
Published: (2018-09-01)